Dr. Dale Bredesen views Alzheimer’s as a complex, multifactorial condition rather than a disease with a single cause.
His ReCODE program uses extensive testing to identify possible contributors to cognitive decline—including metabolic health, inflammation, nutrition, sleep, cardiovascular health, and hormonal factors—and develops an individualized program to address them.
Bredesen emphasizes prevention and early intervention. Published studies of his approach have reported encouraging results, although larger controlled trials are needed.
His central idea particularly interests me: if many factors contribute to cognitive decline, it makes sense to identify and address as many of them as reasonably possible—preferably before significant cognitive decline occurs.
Dr. Bredesen has spent decades studying the mechanisms involved in neurodegenerative disease. He argues that Alzheimer’s is not simply one disease with one cause, but a syndrome that may result from a combination of factors that differ from person to person.
He sometimes compares Alzheimer’s to a “roof with many holes.” Fixing only one hole may not be enough. Similarly, he argues that targeting amyloid with a single drug may have limited effectiveness if insulin resistance, inflammation, poor sleep, nutritional deficiencies, vascular problems, or other contributors remain unaddressed.
His ReCODE program therefore attempts to identify an individual’s particular risk factors and address them simultaneously.
Rather than asking only, “What drug treats Alzheimer’s?” Bredesen asks a different question:
“Why is this particular person experiencing—or at risk for—cognitive decline?”
The ReCODE program begins with a detailed evaluation designed to identify factors that may increase an individual’s risk of cognitive decline. This can include cognitive testing, laboratory tests, medical history, genetics, sleep, diet, exercise, and other aspects of health and lifestyle.
The resulting plan is individualized, but commonly addresses:
Metabolic health — improving insulin sensitivity and blood sugar regulation.
Nutrition — emphasizing nutrient-dense foods and often a mildly ketogenic, low-glycemic diet.
Exercise — combining aerobic activity, strength training, and other movement.
Sleep — improving sleep quality and identifying problems such as sleep apnea.
Stress — reducing chronic stress and incorporating relaxation or mindfulness practices.
Cardiovascular health — addressing blood pressure, lipids, circulation, and other vascular risk factors.
Nutritional deficiencies — identifying and correcting deficiencies when appropriate.
Cognitive and social activity — encouraging continued learning, mental stimulation, and social engagement.
Depending on the individual, the program may also address hormones, inflammation, infections, environmental exposures, and other possible contributors.
The goal is to identify potentially modifiable risks as early as possible and improve the conditions that support a healthy brain.
Evidence increasingly supports the broader idea that multiple modifiable factors influence cognitive health. Exercise, cardiovascular and metabolic health, blood pressure, sleep, diet, and social and cognitive activity have all become important areas of Alzheimer’s prevention research.
Studies specifically evaluating Bredesen-style personalized programs have reported encouraging improvements in some participants with mild cognitive impairment or early Alzheimer’s disease.
However, these studies have generally been small, and the complete ReCODE program has not yet been established by large randomized controlled trials. It is therefore difficult to know how much benefit comes from the overall protocol or from its individual components.
I find the early results encouraging, but I regard the approach as promising rather than proven.
Bredesen’s work has had a major influence on how I think about Alzheimer’s prevention.
What appeals to me most is the emphasis on acting before significant cognitive decline occurs. Rather than waiting for symptoms and then treating them, the approach looks for potentially modifiable risks while a person is still cognitively healthy.
That is particularly meaningful to me because Alzheimer’s and dementia have occurred in my family. Although I have no symptoms, I currently use a medical practice that follows the Bredesen approach.
I cannot know whether these efforts will prevent Alzheimer’s. But I would rather identify and address reasonable risk factors now than wait to see whether cognitive problems develop.
That is why I find Bredesen’s emphasis on prevention, personalization, and metabolic health so compelling.
Information about ReCODE, cognitive-health programs, and Bredesen-trained practitioners.
Directory of practitioners and coaches trained in the Bredesen approach.
A practical guide to Bredesen's approach to preventing and addressing cognitive decline.
Dr. Bredesen's more recent book emphasizing maintaining cognitive health throughout life.
Dr. Bredesen explains his approach to preventing and reversing cognitive decline by identifying and addressing the multiple factors that may contribute to Alzheimer’s disease.
Dr. Bredesen explains his view that Alzheimer's results from multiple contributing factors and describes his personalized approach to identifying and addressing potential causes of cognitive decline.
Dr. Bredesen discusses recent research on his precision-medicine approach to cognitive decline and explains why he emphasizes identifying and addressing multiple potential contributors to Alzheimer’s disease.